Revenio Group Corporation’s Management team
Timo Hildén has over 30 years of experience in general management, and in sales and marketing positions within the health technology sector, at Orion Group, Labsystems, Thermo Electron and Thermo Fisher Scientific. In the early 1990s, he was involved in the launch of production and sales companies in Russia and China, later assuming responsibility for production and marketing units in the USA (3), Mexico and Finland (2). He was also in charge of product development units in Finland and the United States. He was involved in numerous acquisitions while working for Thermo. He has been a member of the board at Medisize Oy (formerly Perlos), as well as at Thermo’s Finnish subsidiary and its foreign affiliates. He was appointed CEO of Icare Finland Ltd on April 9, 2012 and has been a member of Revenio Group’s Management Team since May 22, 2014. He has been the CEO of Revenio Group Corporation since 2017.
Robin Pulkkinen joided Revenio from the position of Symbio´s EMEA area CFO. Priot to this, Pulkkinen held several managerial positions in international corporations both in Finland and Canada. He has solid experience in various financial management roles. Pulkkinen was appointed CFO of Revenio Gropu Corporation on July 15, 2015 and has been a member of Revenio Group´s Management Team since August 6, 2015.
Ari Kukkonen has acted as the R&D Director of Icare Finland years 2011-2018. As of February 2018 Kukkonen has acted as the Senior Advisor of Revenio Group Corporation and member of Extended Management Team at Revenio Group Corporation. Before moving on to Icare Finland, Kukkonen spent several years as Director R&D at Thermo Fisher Scientific, overseeing product development in two business units (Vantaa, Finland and Hudson, USA). Kukkonen has broad international expertise in the development of health technology products. Mr. Kukkonen was appointed a member of Revenio Group’s Management Team starting from August 6, 2015.
Tomi Karvo has spent 20 years working in various managerial positions in international business and sales and marketing in the field of health technology. His former employers include Datex-Ohmeda, Spacelabs, Perlos and Medisize. His latest position was that of Hospital Division Director at Serres Oy. He was one of the forerunners who introduced the Medical IT business to Germany and Austria and has participated in numerous corporate acquisitions while employed by Datex-Ohmeda and Perlos. He was was appointed a member of Revenio Group’s Management Team starting from August 6, 2015.
Ari Isomäki has been Operations Director of Icare Finland since September 2012. He has 20 years of experience of executive positions in production, purchasing and logistics in companies operating in national and international markets, such as Perlos and Ensto. He was appointed a member of Revenio Group’s Management Team from 1 June 2016.
Mika Salkola has workes as R&D Direcotr of Icare Finland since September 2015. Mikas has extensive experience in R&D. He has over 20 years of experience in international R&D operations, among others at Thermo Fisher Scientic and Vaisala. He was appointed a member of Revenio Gropu´s Manatement Team from 1 February, 2018.
Heli Huopaniemi has held the position of QA Manager at Icare Finland since 2010. Previously Heli has worked as QA Manager at Plexpress Oy, as CTO at CTT Cancer Targeting Technologies Ltd and as Research Scientist at University of Helsinki, Haartman Institute. She was appointed a member of Revenio Group’s Management Team from 1 February, 2018.